Strikingly low serum concentrations of TWEAK but not APRIL turned out as a significant prognostic marker for patients’ survival according to Kaplan-Meier curve analysis (Figure 4C,D), highlighting the relevance of TWEAK in the pathogenesis of pancreatic cancer. This evidence concerns the gene TNFSF12 and pancreatic neoplasm.